3 The application of PEFs technology in cancer treatment 3.1 Pancreatic cancer Pancreatic cancer stands as one of the malignancies most frequently targeted by PEFs therapy, which not only significantly suppresses tumor progression but also remodels the immunosuppressive TME, thereby preventing recurrence and metastasis
This configuration provides gastroenterology, immunology, and molecular biology laboratories with a resilient, highly bioavailable vehicle to map localized cytokine suppression, cellular junction restoration, and non-competitive neuro-immune receptor cross-talk
Wound healing in clinical settings, for instance, sometimes uses injected or infused GHK-Cu under medical supervision
Jan 1, 2026 Needle anxiety stops countless people from accessing peptide therapy benefits despite strong interest in compounds like BPC-157 for healing, PT-141 for libido, or cognitive peptides like Semax